Recent blog posts
Global New Drug Research and Development Progress Weekly Report (10.28-11.3)
Drug Highlight
6 min read
Global New Drug Research and Development Progress Weekly Report (10.28-11.3)
5 November 2024
latest updates in the global new drug development field, including progress in new drug research and development.
Read →
Global New Drug Research and Development Progress Weekly Report (9.9-9.15)
Drug Highlight
10 min read
Global New Drug Research and Development Progress Weekly Report (9.9-9.15)
19 September 2024
the FDA approved several new drugs and new indications, including Roche's two blockbuster subcutaneous formulations, Eli Lilly's IL-13 antibody, and Johnson & Johnson's IL-23 antibody.
Read →
Global New Drug Research and Development Progress Weekly Report (9.2-9.8)
Drug Highlight
8 min read
Global New Drug Research and Development Progress Weekly Report (9.2-9.8)
9 September 2024
9.2-9.8 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →
Global New Drug Research and Development Progress Weekly Report(8.26-9.1)
Drug Highlight
16 min read
Global New Drug Research and Development Progress Weekly Report(8.26-9.1)
2 September 2024
8.26-9.1 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →
Global New Drug Research and Development Progress Weekly Report (8.19-8.25)
Drug Highlight
15 min read
Global New Drug Research and Development Progress Weekly Report (8.19-8.25)
26 August 2024
8.19-8.25 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 4)
Drug Highlight
5 min read
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 4)
10 July 2024
This article will continue to review the antitumor targets of the GPCR family and the therapeutic drugs that have been marketed.
Read →
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 3)
Drug Highlight
8 min read
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 3)
10 July 2024
This article will continue to review the antitumor targets of the GPCR family and the therapeutic drugs that have been marketed.
Read →
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 2)
Drug Highlight
6 min read
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 2)
10 July 2024
This article will continue to review the antitumor targets of the GPCR family and the therapeutic drugs that have been marketed.
Read →
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 1)
Drug Highlight
7 min read
GPCR Family Anticancer Targets and Marketed Therapeutic Drugs (Part 1)
10 July 2024
This article will inventory the anti-tumor targets in the GPCR family and the therapeutic drugs that have been marketed.
Read →
Global New Drug Research and Development Progress Weekly Report(7.1-7.7)
Drug Highlight
10 min read
Global New Drug Research and Development Progress Weekly Report(7.1-7.7)
8 July 2024
7.1-7.7 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →
Global New Drug Research and Development Progress Weekly Report(6.24-6.30)
Drug Highlight
14 min read
Global New Drug Research and Development Progress Weekly Report(6.24-6.30)
1 July 2024
6.24-6.30 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →
Global New Drug Research and Development Progress Weekly Report(6.17-6.23)
Drug Highlight
12 min read
Global New Drug Research and Development Progress Weekly Report(6.17-6.23)
24 June 2024
6.17-6.23 Global Drug R&D Progress & Pharmaceutical Transaction Trends.
Read →